Inherited genetics directly shape how our DNA interacts with acquired mutations to drive tumor evolution, according to research published in Nature. Scientists at the University of Cambridge and the University of Edinburgh found that an individual’s genetic background dictates both cancer risk and the specific evolutionary paths tumors take, offering new direction for precision medicine and population-diverse screening strategies.
How Inherited Genetics Dictate Cancer Evolution
Tumors form when cellular DNA accumulates errors that cause rapid growth and override natural cell death signals. While environmental exposures like cigarette smoke or sunlight damage DNA, inherited genetic alterations determine how many mutations accumulate, according to researchers. Although studies long suggested that inherited differences affect cancer risk, proving this link in humans has remained challenging due to varying lifestyles, environments, and exposure histories across populations.
To isolate genetic background from environmental noise, researchers bred four mouse strains with varying susceptibility to liver cancer, matching human population diversity. At 15 days of age, the mice received a single dose of diethylnitrosamine (DEN), a liver carcinogen found in tobacco smoke and processed foods. By controlling exposure timing and dosage, the team eliminated environmental confounding variables. Sequencing nearly 600 tumors revealed how each cancer evolved from its original mutation.
Across all four strains, cancers consistently acquired a driver mutation activating the MAPK signaling system, a molecular cascade controlling cell growth and differentiation. However, depending on the mouse’s inherited genetics, that specific driver mutation altered secondary cancer-associated pathways and triggered widespread whole-genome duplication, where an entire set of chromosomes doubles.
“Cancer does not arise entirely by chance. Although tumors often reach the same biological endpoint, the path to that endpoint is determined by an individual’s genetic background,” said senior author Professor Duncan Odom, who led the research while at the CRUK Cambridge Institute and is now based at the DKFZ (German Cancer Research Centre) in Heidelberg, Germany.
Implications for Cancer Screening and Precision Medicine
The findings indicate that response to DNA-damaging treatments may vary significantly depending on a patient’s background genetics. Because inherited genetics influence both cancer risk and tumor trajectories, future prevention strategies must account for population diversity, according to the study authors.
First author Dr. Sarah Aitken, Assistant Professor at Yale School of Medicine and former researcher at the CRUK Cambridge Institute, noted that diagnostics and treatments may need to adapt. “How people respond to cancer drugs is likely to differ depending on their inherited genetics, and so we may need to tailor our diagnostics and treatments accordingly,” Dr. Aitken said.
Did you know? Most cigarette smokers do not develop lung cancer, while some non-smokers do. Researchers point to inherited genetic makeup as the underlying reason for this divergence in susceptibility under identical environmental exposures.
Dr. Sam Godfrey, research information lead at Cancer Research UK, stated that the study provides a fascinating hint regarding how inherited genes influence cancer development after DNA damage. While further research is needed to fully translate these findings to human patients, the work establishes direct experimental evidence that genetics set the evolutionary trajectory of experimental cancer evolution.
Frequently Asked Questions
What role do inherited genes play in cancer risk?
Inherited genetics interact with acquired mutations to influence how tumors evolve, dictating both overall cancer susceptibility and the specific evolutionary pathways a tumor takes, according to research published in Nature.
Why is it difficult to study inherited cancer risk in humans?
Proving the direct link between inherited genetics and cancer risk in human populations is challenging because individuals vary widely in lifestyle, environment, and exposure history.
How did researchers isolate genetic background from environmental factors?
Scientists controlled environmental factors by breeding four mouse strains with diverse genetics and administering an identical dose of a liver carcinogen at 15 days of age under controlled conditions.
What funding organizations supported this research?
The study was primarily funded by Cancer Research UK, the Medical Research Council, the European Research Council, and Wellcome.
Explore More: Dive deeper into our ongoing coverage of precision medicine and cancer research breakthroughs to stay informed on the latest peer-reviewed findings.
Related reading